| EPE1004 | Preferred models of clinical service delivery for HIV pre-exposure prophylaxis (PrEP) users in the COVID-19 era: a discrete choice experiment among men who have sex with men (MSM) in Australia | E-poster | Impact of COVID-19 on HIV prevention, testing and treatment (including financing) |
| TUPED12 | Preferences of gbMSM regarding sexual orientation disclosure interventions in primary care: a qualitative content analysis | Poster exhibition | Key populations and other vulnerable populations: Behavioural, social and cultural issues and contexts |
| EPC0366 | Preferences for non-surgical and surgical VMMC among adolescents and their parents in Zimbabwe: findings from a cross-sectional study | E-poster | HIV prevention research |
| LBEPC26 | Preferences for long-acting HIV pre-exposure prophylaxis (PrEP) formulations among East and Southern African women – evidence from a discrete choice experiment (DCE) | E-poster | HIV prevention research |
| EPE0945 | Preferences for hypertension care among people living with HIV in Malawi: a discrete choice experiment (DCE) | E-poster | Integration of HIV services with other health and support services |
| EPE0779 | Preferences for HIV testing among youth in sub-Saharan Africa: a systematic review of discrete choice experiments | E-poster | Implementation science and scale up of HIV testing |
| EPC0372 | Preferences for a community pharmacy-based PrEP delivery program: a discrete choice experiment | E-poster | HIV prevention research |
| MOPEE09 | Preference heterogeneity among potential users of online pre-exposure prophylaxis provision in Kenya: a discrete choice experiment | Poster exhibition | Implementation science and scale up of prevention |
| EPC0356 | Pre-exposure prophylaxis (PrEP) uptake & associated factors among adolescent girls and young women (15-20) participating in HPV vaccine trial | E-poster | HIV prevention research |
| TUPEA12 | Pre-existing immunity restricts plasma and mucosal antibody responses during SARS-CoV-2 Omicron breakthrough infection | Poster exhibition | SARS-CoV-2 virology, pathogenesis, and host immune responses, vaccines and immunotherapies |